Katarzyna Ewa Ożegowska - Gynecology

Author Information

Katarzyna Ewa Ożegowska is affiliated with the Division of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics and Gynecological Oncology at Poznan University of Medical Sciences, located in Poznań, Poland. Her research primarily focuses on reproductive endocrinology, particularly in relation to conditions such as polycystic ovary syndrome (PCOS) and type 1 diabetes.

Research Contributions

Katarzyna Ewa Ożegowska has made significant contributions to the field of gynecology and reproductive endocrinology. Her research has explored various aspects of PCOS, including its metabolic and endocrinologic parameters, the relationship between type 1 diabetes and PCOS diagnosis, and the impact of different body mass indices on serum metabolomics in women with PCOS. She has also investigated novel markers of ovarian granulosa cell differentiation and has contributed to the understanding of coagulation disturbances in PCOS patients. Additionally, her work has delved into the properties and clinical applications of human Wharton’s jelly mesenchymal stem cells.

Aliases

Katarzyna Ewa Ożegowska is also known by several aliases, including Katarzyna E Ozegowska, Katarzyna Ozegowska, Katarzyna Ożegowska, and K Ożegowska.

Publication and Citation Metrics

Metric	Value
Citation Count	430
H-Index	13
Paper Count	41

Publications:

The influence of prepubertal onset of type 1 diabetes and age of menarche on polycystic ovary syndrome diagnosis.

DOI: 10.1210/clinem/dgab062

Year: 2021

Serum Metabolomics in PCOS Women with Different Body Mass Index

DOI: 10.3390/jcm10132811

Year: 2021

Novel markers of human ovarian granulosa cell differentiation toward osteoblast lineage: A microarray approach

DOI: 10.3892/mmr.2021.12308

Year: 2021

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis

DOI: 10.3390/ijerph17249291

Year: 2020

New markers for regulation of transcription and macromolecule metabolic process in porcine oocytes during in vitro maturation

DOI: 10.3892/mmr.2020.10963

Year: 2020

Can Total Thrombus-formation Analysis System (T-TAS®) better predict coagulation disturbances than conventional laboratory measurements in patients with polycystic ovary syndrome?

DOI: 10.20452/pamw.15633

Year: 2020

Human Wharton’s Jelly—Cellular Specificity, Stemness Potency, Animal Models, and Current Application in Human Clinical Trials

DOI: 10.3390/jcm9041102

Year: 2020

Thyroid peroxidase antibodies in women with polycystic ovary syndrome and type 1 diabetes

DOI: 10.1530/endoabs.70.ep376

Year: 2020

Relationship between adipocytokines and angiotensin converting enzyme gene insertion/deletion polymorphism in lean women with and without polycystic ovary syndrome

DOI: 10.1080/09513590.2019.1695248

Year: 2019

Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.

DOI:

Year: 2019

What causes a yeast infection?

What is an Appeal in Gynecology?

What is an MRI Scanner?

How is Dosage Determined?

At What Age Should Women Receive These Vaccines?

How Important is a Supportive Work Environment?

What is Gallbladder Disease?

What Are the Signs of Domestic Violence in Gynecological Patients?

What is Epocrates?

What Are Multiple Gestations?

Partnered Content Networks

Relevant Topics